Skip to content

Effect of Modified PENG Block on Postoperative Analgesia After Total Hip Arthroplasty

Effect of Modified PENG Block on Postoperative Analgesia After Total Hip Arthroplasty

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115502
Enrollment
Unknown
Registered
2025-12-26
Start date
2024-12-22
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

analgesic after total hip arthroplasty.

Interventions

Modified PENG Block Group:Modified PENG Block
Lateral Femoral Cutaneous Nerve Block Group:Lateral Femoral Cutaneous Nerve Block
PENG Block Group:PENG Block

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Body Mass Index (BMI): 18-26 kg/m^2 (inclusive of boundary values); 2.Patients scheduled for total hip arthroplasty. 3.ASA classification of 1-3. 4.Voluntary participation in this study with a signed informed consent form. If the participant is unable to read or sign the informed consent form due to incapacity, their legal guardian must oversee the informed consent process and sign the form on their behalf. For participants unable to read the informed consent form (e.g., illiterate individuals), a witness must be present during the informed consent process and sign the form as a witness; 5.18-80 years old (including boundary values).

Exclusion criteria

Exclusion criteria: 1.Severe diseases of major organs and systems; 2.Inability to tolerate general anesthesia; 3.Chronic pain conditions; 4.Coagulation disorders; 5.Infection at the injection site; 6.Peripheral nervous system disorders; 7.Inability to communicate or cooperate; 8.History of allergy to local anesthetics; 9.Contraindications to any of the drugs used in the study protocol; 10.Vulnerable populations other than the elderly or illiterate individuals, including those with: psychiatric disorders, cognitive impairment, critical illness, pregnancy, etc.

Design outcomes

Primary

MeasureTime frame
Consumption of sufentanil;

Secondary

MeasureTime frame
Hip joint range of motion;Maximum NRS (Numerical Rating Scale) score;Time to first rescue analgesia;Consumption of sufentanil;The QoR-15 Quality of Recovery Scale;Postoperative adverse events;Quadriceps Manual Muscle Testing;Measuring the area of skin sensory block with cold stimulation;First time walking;

Countries

China

Contacts

Public ContactXing Zheng

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

iamzx1978@163.com+86 571 8609 0073

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026